Pridopidine
CAS No. 346688-38-8
Pridopidine ( ACR16;FR-310826;ASP-2314;Huntexil )
产品货号. M14190 CAS No. 346688-38-8
Pridopidine (ACR16, FR-310826, ASP-2314, Huntexil) is a specific dopamine stabilizer without no partial agonism.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥275 | 有现货 |
|
5MG | ¥551 | 有现货 |
|
10MG | ¥956 | 有现货 |
|
25MG | ¥1855 | 有现货 |
|
50MG | ¥2778 | 有现货 |
|
100MG | ¥4026 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Pridopidine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Pridopidine (ACR16, FR-310826, ASP-2314, Huntexil) is a specific dopamine stabilizer without no partial agonism.
-
产品描述Pridopidine (ACR16, FR-310826, ASP-2314, Huntexil) is a specific dopamine stabilizer without no partial agonism; shows robust dose-dependent striatal D2 occupancy with ED50 of 18.99 mg/kg s.c. in vivo, shows high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in rats.Parkinson Disease Discontinued
-
同义词ACR16;FR-310826;ASP-2314;Huntexil
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体Dopamine Receptor
-
研究领域Neurological Disease
-
适应症Parkinson Disease
化学信息
-
CAS Number346688-38-8
-
分子量281.41
-
分子式C15H23NO2S
-
纯度>98% (HPLC)
-
溶解度DMSO : 50 mg/mL 177.68 mM
-
SMILESO=S(C1=C(F)C(C2CCN(CC)CC2)=CC=C1)(C)=O
-
化学全称4-(3-(methylsulfonyl)phenyl)-1-propylpiperidin
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Natesan S, et al. J Pharmacol Exp Ther. 2006 Aug;318(2):810-8.
2. Nilsson M, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):677-85.
3. Seeman P, et al. Synapse. 2009 Oct;63(10):930-4.
4. Pettersson F, et al. J Med Chem. 2010 Mar 25;53(6):2510-20.
2. Nilsson M, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):677-85.
3. Seeman P, et al. Synapse. 2009 Oct;63(10):930-4.
4. Pettersson F, et al. J Med Chem. 2010 Mar 25;53(6):2510-20.
产品手册
关联产品
-
Bromopride
Bromopride is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic.
-
Syrosingopine
Syrosingopine has selective depleting effect on brain amines is potentiated by combined treatment with disulfiram or fusaric acid, a dopamine beta-hydroxylase inhibitor.
-
PF-592379
A potent, selective, orally active agonist of dopamine D3 receptor with EC50 of 21 nM; displays >470 and 180-fold functional selectivity over D2 and D4 dopamine receptors, respectively.